Patients with cancer-associated venous thromboembolism and chronic kidney disease were at increased risk for major bleeding during anticoagulant treatment, according to study results.
Results from a large retrospective study suggest that controlling the activation of the renin-angiotensin system (RAS) with antihypertensive medications reduces the risk of atrial fibrillation.
New phase 2 data presented at the American Society of Hematology Annual Meeting demonstrate that andexanet alfa effectively reversed the anticoagulation activity of rivaroxaban.
Patients with atrial fibrillation are at higher risk for stroke in the first month after initiating treatment with the anti-clotting drug warfarin, study findings indicate.
Admission to hospital during pregnancy for reasons other than delivery carries a substantially increased risk of serious blood clots (known as venous thromboembolism or VTE), finds a study published in BMJ.
The use of novel oral anticoagulants in patients with atrial fibrillation is low in Europe, and compliance with European treatment guidelines for AF is suboptimal in those at the lowest and highest risk for stroke, according to a report by the European Society of Cardiology.
Fixed low-dose, ultrasound-assisted, catheter-directed thrombolysis rapidly reverses hemodynamic impairment in patients with higher-risk pulmonary embolism, according to a study published online December 13, 2013, ahead of print in the European Heart Journal.
Enhanced pacemaker technology sharply reduced progression of nonpermanent atrial fibrillation to permanent AF in patients with bradycardia and sinus node disease in the large international, randomized MINERVA trial.
Once-daily edoxaban is noninferior to warfarin for prevention of stroke or systemic embolism; and genotype-guided dosing of warfarin may be beneficial, according to three studies published online Nov. 19 in the New England Journal of Medicine.
Patients better adhered to their medication regimens in the year following hospitalization for acute coronary syndrome (ACS) when they were part of a program that included personalized attention from a pharmacist compared with usual care, according to a study by P. Michael Ho, M.D., Ph.D., of the Denver VA Medical Center, and colleagues.
Pregnant women who enter the hospital for reasons unrelated to their pregnancy face a sharply increased risk for thromboembolism during their stay and several weeks thereafter, a new study suggests.
Doctors have known for years that atrial fibrillation (AF), or irregular heartbeat, increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart attack. In fact, for women and African Americans, it more than doubles the risk.
The risk of venous thromboembolism (VTE) in young trauma patients increased most dramatically from ages 16 to 21, findings that could help develop standardized protocols for VTE prophylaxis in pediatric trauma, researchers noted.
By World Stroke Day 2013 (October 29) more than 500,000 people have shown their support for the Sign Against Stroke in Atrial Fibrillation campaign, calling for urgent coordinated action to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients disabled or dead every year.
Emergency department patients with a pulmonary embolism or deep vein thrombosis can be treated as outpatients, growing evidence suggests.
In patients with left main or triple-vessel coronary artery disease, stent thrombosis after percutaneous coronary intervention (PCI) occurs with roughly the same frequency as graft occlusion following coronary artery bypass grafting (CABG). However, stent thrombosis is more likely to result in mortality in both the short and long term, according to 5-year results of the SYNTAX trial published online October 16, 2013, ahead of print in the Journal of the American College of Cardiology.
Treatment of pulmonary embolism with rivaroxaban was associated with cost savings of more than $2,000 per patient compared with treatment with enoxaparin plus warfarin, according to new findings from the EINSTEIN-PE study.
There are multiple independent risk factors for the development of deep venous thrombosis (DVT) and/or pulmonary embolism (PE) after spine surgery, according to a study published in the Oct. 1 issue of Spine.
New findings suggest that race or ethnic background is the primary factor in developing a common heart condition called atrial fibrillation.
The usefulness of postoperative venous thromboembolism (VTE) quality measures is limited by surveillance bias -- the more events you look for, the more you find, a study reports.